Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE Attacks in Japan
Clinical trial NCT03873116 · COMPLETED
Trial details
- NCT number
- NCT03873116
- Sponsor
- BioCryst Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-27
- Primary completion
- 2021-07-08
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.